— Know what they know.
Not Investment Advice

KALY OTC

Kali, Inc.
1W: +0.0% 1M: +9900.0% 3M: +0.0% YTD: +100.0% 1Y: +100.0% 3Y: +999900.0% 5Y: +90809.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 55 · $101824 mcap · 771M float · 0.034% daily turnover · Short 41% of daily vol

Cash Flow Trends

Operating Cash Flow
-$248 +97.3% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$248 +97.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$248 +68.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2010FY2011FY2012FY2017FY2018
— Operating Activities —
Net Income$15M$14M$18M-$9K-$12K
Depreciation & Amort.$71K$2M$975K$0$0
Stock-Based Comp.$0$254K$518K$0$0
Change in Working Capital-$12M-$8M-$6M$77K$12K
Other Non-Cash Items-$2M$13M-$134K-$144K-$12K
Operating Cash Flow$1M$7M$13M-$9K-$248
— Investing Activities —
Capital Expenditures-$9K-$2M-$502K$0$0
Acquisitions (Net)$0-$7M$0$0$0
Investment Purchases-$3M$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$3M$4M$79K$0$0
Investing Cash Flow-$3M-$5M-$423K$0$0
— Financing Activities —
Net Debt Issuance$2M$382K$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0-$397K$0$0
Financing Cash Flow$2M$382K-$397K$0$0
Net Change in Cash$977K$3M$12M-$788-$248
Cash End of Period$12M$15M$27M$760$512
Free Cash Flow$1M$4M$12M-$9K-$248

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms